血清降钙素原作为菌血症预示因子临床价值的研究

doi:10.3969/j.issn.1673-8640.2014.08.004

摘要/Abstract

摘要： 目的探讨血清降钙素原(PCT)与菌血症之间的关系,评价血清PCT在预测血培养确证的菌血症方面的诊断价值。方法采用回顾性研究,以同时进行血培养及PCT检测的1 690例患者为研究对象,对其结果进行分析。研究对象分为3组,即血培养阳性组(129例)、血培养阴性组(1 463例)和血培养污染组(98例),比较3组之间PCT浓度的差异,并将血培养阳性组分为革兰阴性菌组、革兰阳性菌组和假丝酵母菌组,从而进一步比较PCT浓度在阳性组内的差异。结果血培养阳性组PCT浓度高于血培养阴性组和血培养污染组[中位数(四分位数)分别为2.62(0.3712.80)、 0.17(0.070.62)和 0.20(0.090.72) ng/mL,P<0.000 1]。革兰阴性菌组、假丝酵母菌组和革兰阳性菌组PCT阳性率分别为74.5%、37.5%和66.7%,PCT浓度[中位数(四分位数)]分别为6.24(0.4316.09)、0.47(0.223.18)和1.09(0.244.05) ng/mL,革兰阴性菌组PCT浓度明显高于革兰阳性菌组和假丝酵母菌组(P<0.05)。结论除临床其他指标外,PCT作为一种可靠的检测指标,可用于排除血培养的污染和非感染性疾病情况,为菌血症提供早期的预示信息,从而改善和提高菌血症诊断的准确性,避免非必需的抗菌药物治疗,对临床诊疗具有很大的临床意义。

关键词: 降钙素原, 菌血症, 血培养

Abstract: Objective To investigate the relationship of serum procalcitonin (PCT) and bacteremia,and to evaluate the diagnosis significance of serum PCT to predict bacteremia determined by blood cultures. Methods A total of 1 690 patients undergoing blood cultures and PCT were concurrently enrolled for detecting bacteremia by retrospective analysis. The patients were classified into blood culture positive group(129 cases), blood culture negative group(1 463 cases) and contaminated blood culture group(98 cases). According to the difference of PCT concentration, the blood culture positive group was subclassified into 3 groups, gram-negative bacterium group, gram-positive bacterium group and Candida mycoderma group. The difference of PCT concentration in the blood culture positive group was further analyzed comparatively. Results The concentration of PCT in blood culture positive group was higher than those of blood culture negative group and contaminated blood culture group [medians(quartiles) were 2.62(0.37-12.80), 0.17(0.07-0.62) and 0.20(0.09-0.72) ng/mL, P<0.000 1]. In gram-negative bacterium group, Candida mycoderma group and gram-positive bacterium group, the positive rates of serum PCT were 74.5%, 37.5% and 66.7%, respectively, while the PCT concentrations [medians (quartiles) were 6.24(0.43-16.09), 0.47(0.22-3.18) and 1.09(0.24-4.05) ng/mL. PCT concentration in gram-negative bacterium group was higher than those in gram-positive bacterium group and Candida mycoderma group (P<0.05). Conclusions In addition to other clinical parameters, PCT is a reliable parameter for ruling out blood culture contamination and non-bacterial conditions. PCT is effective as a parameter for predicting early bacteremia, and is able to improve the accuracy of diagnosis and avoid the unnecessary antimicrobial usage. PCT has great clinical significance for the clinical diagnosis and treatment.

Key words: Procalcitonin, Bacteremia, Blood culture

中图分类号:

R446.1

侯伟伟, 肖倩茹, 江涟, 万海英. 血清降钙素原作为菌血症预示因子临床价值的研究[J]. 检验医学, 2014, 29(8): 802-805.

HOU Weiwei, XIAO Qianru, JIANG Lian, WAN Haiying. Research on the clinical significance of serum procalcitonin in predicting bacteremia[J]. , 2014, 29(8): 802-805.

参考文献

[1] Jeong S,Park Y,Cho Y, et al. Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture[J]. Clin Chim Acta, 2012,413 (21-22): 1731-1736.
[2] Hall KK, Lyman JA. Updated review of blood culture contamination[J]. Clin Microbiol Rev, 2006,19(4): 788-802.
[3] Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative Staphylococci [J]. Infection, 2007, 35(5): 352-355.
[4] Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection[J]. Pediatr Infect Dis J, 2000,19(8): 679-687.
[5] Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection[J]. Intensive Care Med, 2000, 26(9):1193-1200.
[6] Meisner M, Schmidt J, Huttner H, et al. The natural elimination rate of procalcitonin in patients with normal and impaired renal function[J]. Intensive Care Med, 2000, 26(Suppl 2): S212-S216.
[7] Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis[J]. Am J Respir Crit Care Med, 2001, 164(3): 396-402.
[8] Wanner GA, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients[J]. Crit Care Med, 2000, 28(4): 950-957.
[9] Meisner M, Rauschmayer C, Schmidt J, et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications[J]. Intensive Care Med, 2002, 28(8):1094-1102.
[10] Sauerland S, Hensler T, Bouillon B, et al. Plasma levels of procalcitonin and neopterin in multiple trauma patients with or without brain injury[J]. J Neurotrauma, 2003, 20(10): 953-960.
[11] Christ-Crain M, Müller B. Procalcitonin in bacterial infections-hype, hope, more or less[J]. Swiss Med Wkly, 2005,135(31-32): 451-460.
[12] Gogos CA, Drosou E, Bassaris HP, et al. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options[J]. J Infect Dis, 2000, 181(1): 176-180.
[13] Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria[J]. BMC Infect Dis, 2008, 8:38.
[14] Kim MH, Lim G, Kang SY, et al. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever[J]. Yonsei Med J, 2011, 52(2): 276-281.

[1]	李莉, 孙海燕, 李媛睿, 窦敏, 汤文, 蒋黎敏, 沈立松. 先天性心脏病患儿围手术期NT-proBNP、 PCT变化及其临床意义[J]. 检验医学, 2023, 38(6): 524-531.
[2]	陈晗璐, 吴盛海. 血培养阴性血流感染影响因素及实验室检测研究进展[J]. 检验医学, 2022, 37(7): 688-694.
[3]	翟莎娜, 孙清海, 余永武, 叶芳, 刘茂东. 万古霉素联合美罗培南对PDRP患者疗效及血清TNF-α、PCT、IL-6水平和腹膜液WBC计数的影响[J]. 检验医学, 2022, 37(4): 360-364.
[4]	褚敏君, 李小娟, 黄海林, 李珏, 麻明彪, 杜廷义, 王海平. 延迟放瓶对2种自动化血培养系统苛养菌培养的影响[J]. 检验医学, 2022, 37(3): 209-212.
[5]	顾峰, 吴艳芬, 赵歆晖, 侯照远, 王志宏, 齐华林. 降钙素原水平与维持性血液透析患者全因死亡的关系[J]. 检验医学, 2022, 37(2): 134-140.
[6]	何学联, 何子翼, 刘月阳, 余炎芝, 张思颖. 基于外周血炎症指标的列线图模型早期诊断新生儿败血症的价值[J]. 检验医学, 2022, 37(10): 921-927.
[7]	杨溪, 宋文琪, 董方, 孟庆盈, 甄景慧, 周为. 革兰染色与MALDI-TOF MS在快速鉴定儿童阳性血培养病原菌种类中的应用[J]. 检验医学, 2022, 37(10): 969-973.
[8]	李妍淳, 田彬, 岳娜, 胡志东. 2014—2020年天津某院真菌血症病原菌分布及耐药性分析[J]. 检验医学, 2021, 36(8): 800-804.
[9]	李亚周, 马炜, 刘云, 万玉香, 黄晓春, 秦琴. 多指标联合检测在血流感染早期诊断中的价值[J]. 检验医学, 2021, 36(8): 847-850.
[10]	余佳佳, 李媛睿, 刘瑛. SDS和SAP前处理联合MALDI-TOF MS在报阳血培养样本快速病原菌鉴定中的价值[J]. 检验医学, 2021, 36(8): 864-868.
[11]	侯伟伟, 江涟, 李冬. MALDI-TOF MS直接鉴定血培养阳性病原的临床应用[J]. 检验医学, 2021, 36(4): 424-429.
[12]	乔玉莉, 黄宗帅, 田月如, 关明, 蒋晓飞. 血培养瓶增菌法快速鉴定和快速药物敏感性试验可行性分析[J]. 检验医学, 2021, 36(3): 270-274.
[13]	朱传新, 周玉平, 何艳, 周琴. NLR、CRP、PCT、DD、NT-proBNP在重症COVID-19中的诊断价值[J]. 检验医学, 2021, 36(2): 190-193.
[14]	赵亚楠, 曹啟新, 赵建平. 血培养阳性报警时间在微生物初步鉴定中的价值[J]. 检验医学, 2021, 36(12): 1210-1214.
[15]	潘锡龙, 徐志远, 谢锋, 李丹. 不同脓毒症诊断标准中降钙素原的临床意义[J]. 检验医学, 2021, 36(12): 1215-1218.